Nothing Special   »   [go: up one dir, main page]

ATE283042T1 - Parenterale lösungen enthaltend propofol (2,6- diisopropylphenol) und 2.5-di-0-methyl-1.4;3.6- dianhydro-d-glucitol als lösungsmittel - Google Patents

Parenterale lösungen enthaltend propofol (2,6- diisopropylphenol) und 2.5-di-0-methyl-1.4;3.6- dianhydro-d-glucitol als lösungsmittel

Info

Publication number
ATE283042T1
ATE283042T1 AT99962490T AT99962490T ATE283042T1 AT E283042 T1 ATE283042 T1 AT E283042T1 AT 99962490 T AT99962490 T AT 99962490T AT 99962490 T AT99962490 T AT 99962490T AT E283042 T1 ATE283042 T1 AT E283042T1
Authority
AT
Austria
Prior art keywords
diisopropylphenol
dianhydro
glucitol
solvents
methyl
Prior art date
Application number
AT99962490T
Other languages
English (en)
Inventor
Dinesh Shantilal Patel
Shashikant Prabhudas Kurani
Original Assignee
Dinesh Shantilal Patel
Shashikant Prabhudas Kurani
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dinesh Shantilal Patel, Shashikant Prabhudas Kurani filed Critical Dinesh Shantilal Patel
Application granted granted Critical
Publication of ATE283042T1 publication Critical patent/ATE283042T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
AT99962490T 1999-01-28 1999-09-13 Parenterale lösungen enthaltend propofol (2,6- diisopropylphenol) und 2.5-di-0-methyl-1.4;3.6- dianhydro-d-glucitol als lösungsmittel ATE283042T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN65BO1999 1999-01-28
PCT/IN1999/000044 WO2000044369A1 (en) 1999-01-28 1999-09-13 Parenteral solution of propofol (2,6-diisoprophylphenol) and 2.5- di- 0- methyl- 1.4;3.6- dianhydro- d- glucitol as a solvent

Publications (1)

Publication Number Publication Date
ATE283042T1 true ATE283042T1 (de) 2004-12-15

Family

ID=11077269

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99962490T ATE283042T1 (de) 1999-01-28 1999-09-13 Parenterale lösungen enthaltend propofol (2,6- diisopropylphenol) und 2.5-di-0-methyl-1.4;3.6- dianhydro-d-glucitol als lösungsmittel

Country Status (9)

Country Link
US (1) US6071974A (de)
EP (1) EP1143962B1 (de)
CN (1) CN1151782C (de)
AT (1) ATE283042T1 (de)
AU (1) AU1888700A (de)
DE (1) DE69922252T2 (de)
ES (1) ES2232195T3 (de)
PT (1) PT1143962E (de)
WO (1) WO2000044369A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN188917B (de) * 2000-12-07 2002-11-23 Bharat Surums & Vaccines Ltd
AU2003260943A1 (en) * 2003-06-10 2005-01-04 Shashikant Prabhudas Kurani Improved novel, clear, painless preparation of propofol
US20080171687A1 (en) * 2004-09-16 2008-07-17 Abraxis Bioscience, Inc. Compositions And Methods For The Preparation And Administration Of Poorly Water Soluble Drugs
KR101457834B1 (ko) * 2005-08-31 2014-11-05 아브락시스 바이오사이언스, 엘엘씨 증가된 안정성을 가진 수 난용성 약물의 조성물 및 제조 방법
ES2663324T3 (es) 2005-08-31 2018-04-12 Abraxis Bioscience, Llc Composiciones que comprenden docetaxel con estabilidad incrementada

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
EP0778775B1 (de) * 1994-09-01 1999-01-20 PHARMACIA & UPJOHN COMPANY Tirilazad parentale formulierung mit einem co-lösungsmittel
MY129435A (en) * 1994-10-26 2007-04-30 Novartis Ag Pharmaceutical microemulsion preconcentrates
US5637625A (en) * 1996-03-19 1997-06-10 Research Triangle Pharmaceuticals Ltd. Propofol microdroplet formulations
CH692322A5 (it) * 1997-05-26 2002-05-15 Westy Ag Formulazione iniettabile limpida di Propofol.

Also Published As

Publication number Publication date
EP1143962A1 (de) 2001-10-17
CN1151782C (zh) 2004-06-02
DE69922252T2 (de) 2005-12-01
AU1888700A (en) 2000-08-18
EP1143962B1 (de) 2004-11-24
WO2000044369A1 (en) 2000-08-03
DE69922252D1 (de) 2004-12-30
PT1143962E (pt) 2005-03-31
CN1334725A (zh) 2002-02-06
US6071974A (en) 2000-06-06
ES2232195T3 (es) 2005-05-16

Similar Documents

Publication Publication Date Title
GB0117583D0 (en) Novel compounds
CA2326655A1 (en) Disinfecting compositions and processes for disinfecting surfaces
EA200601847A1 (ru) Замещённые метиларил- или гетероариламидные соединения
DE69739049D1 (de) Flüssigkristallverbindungen, Flüssigkristalle enthaltende Zubereitungen, und aus diesen Verbindungen hergestellte Flüssigkristallanzeigen
EA200601830A1 (ru) Ортозамещённые арильные или гетероарильные амидные соединения
AP9701039A0 (en) Derivatives of 2- (2-oxo-ethlidene)-imidazolidin-4-one.
CA2420996A1 (en) Substituted heterocyclic compounds for treating multidrug resistance
BR9707064A (pt) Novos derivados 19-nor-pregneno
PT1075259E (pt) Novos analogos gordos para o tratamento de diabetes
WO2007099162A3 (fr) Derive de resveratrol a longue chaine hydroxylee utiles comme neurotrophiques
AU1085492A (en) New n-myristoyltransferase inhibitors, process for preparing these and pharmaceutical compositions containing them
AR053559A1 (es) Compuestos derivados antibacterianos de 2,4' -dihidroxifenilo 3',5-disustituidos y metodos relacionados
EA200501148A1 (ru) Пиридилоксиметильные и бензизоксазольные азабициклические производные
MY140325A (en) Indanyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them
ATE283042T1 (de) Parenterale lösungen enthaltend propofol (2,6- diisopropylphenol) und 2.5-di-0-methyl-1.4;3.6- dianhydro-d-glucitol als lösungsmittel
HUP0004704A2 (hu) Dihidrofuro[3,4-b]kinolin-1-on-származékok, eljárás ezek előállítására és ezeket tartalmazó gyógyászati készítmények
KR900016178A (ko) 2-치환 n,n'-디트리메톡시벤조일 피페라진, 그의 제조 방법 및 그를 함유하는 치료 조성물
SE0001865D0 (sv) Management of septic shock
WO1999023092A3 (en) 3-aminoalkylamino-2h-1,4-benzoxa(thia-)zines and pharmaceutical compositions containing them
EP1390343A4 (de) Neue retinoidderivate und verfahren zur herstellung dieser verbindungen, sowie eine pharmazeutische anti-krebs-zusammensetzung, die diese verbindungen enthält
ATE477263T1 (de) Zusammensetzung enthaltend ferrocen-derivate und treibstoff diese enthaltend
EA200600022A1 (ru) Применение производных бицикло [2.2.1] гептана для приготовления нейропротекторных фармацевтических композиций
IL159841A0 (en) Pharmaceutical composition for the treatment of the decline and/or damage of cognitive functions
CA2440186A1 (en) Medicinal composition containing 1,3-thiazine derivative
EA200000527A2 (ru) Новые бициклические амино-пиразиноновые соединения, способ их получения и фармацевтические композиции, содержащие их

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1143962

Country of ref document: EP